Pfizer asks Canada for 5-11s

Pfizer yesterday asked Health Canada to approve its COVID-19 vaccine for children aged 5 to 11 years of age. The proposed doses are about one-third the size of those given to those 12 and up.

To date, Pfizer has delivered over 46 million doses to Canada. Pfizer does note that the children’s vials may have to be delivered anew as opposed to re-dosing the ones already available in the country. This, they say, is because the formulation of the vaccine has shifted slightly.

These recommendations will be evaluated and examined by the Regulator.

Pfizer already submitted clinical trial data for its child-sized dose to Health Canada at the beginning of the month, and made a formal request for approval to the U.S. Food and Drug Administration last week.

The company said the results were comparable to those recorded in the Pfizer-BioNTech study in people aged 16 to 25.